Annual Operating Profit
-$340.00 M
-$60.00 M-21.43%
31 December 2023
Summary:
Arcus Biosciences annual operaing income is currently -$340.00 million, with the most recent change of -$60.00 million (-21.43%) on 31 December 2023. During the last 3 years, it has fallen by -$216.00 million (-174.19%). RCUS annual operating profit is now -729.63% below its all-time high of $54.00 million, reached on 31 December 2021.RCUS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$105.00 M
+$1.00 M+0.94%
30 September 2024
Summary:
Arcus Biosciences quarterly operating income is currently -$105.00 million, with the most recent change of +$1.00 million (+0.94%) on 30 September 2024. Over the past year, it has dropped by -$25.00 million (-31.25%). RCUS quarterly operating profit is now -137.36% below its all-time high of $281.02 million, reached on 31 December 2021.RCUS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$298.00 M
-$25.00 M-9.16%
30 September 2024
Summary:
Arcus Biosciences TTM operating income is currently -$298.00 million, with the most recent change of -$25.00 million (-9.16%) on 30 September 2024. Over the past year, it has increased by +$25.00 million (+7.74%). RCUS TTM operating profit is now -497.23% below its all-time high of $75.02 million, reached on 30 September 2022.RCUS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.4% | -31.3% | +7.7% |
| 3 y3 years | -174.2% | -34.4% | -6.9% |
| 5 y5 years | -519.8% | -351.6% | -252.0% |
RCUS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -729.6% | at low | -137.4% | +0.9% | -497.2% | +12.3% |
| 5 y | 5 years | -729.6% | at low | -137.4% | +0.9% | -497.2% | +12.3% |
| alltime | all time | -729.6% | at low | -137.4% | +0.9% | -497.2% | +12.3% |
Arcus Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$105.00 M(-0.9%) | -$298.00 M(+9.2%) |
| June 2024 | - | -$106.00 M(-2750.0%) | -$273.00 M(+9.2%) |
| Mar 2024 | - | $4.00 M(-104.4%) | -$250.00 M(-26.5%) |
| Dec 2023 | -$340.00 M(+21.4%) | -$91.00 M(+13.8%) | -$340.00 M(+5.3%) |
| Sept 2023 | - | -$80.00 M(-3.6%) | -$323.00 M(+3.2%) |
| June 2023 | - | -$83.00 M(-3.5%) | -$313.00 M(+4.7%) |
| Mar 2023 | - | -$86.00 M(+16.2%) | -$299.00 M(+6.8%) |
| Dec 2022 | -$280.00 M(-618.5%) | -$74.00 M(+5.7%) | -$280.00 M(-473.2%) |
| Sept 2022 | - | -$70.00 M(+1.4%) | $75.02 M(+12.2%) |
| June 2022 | - | -$69.00 M(+3.0%) | $66.88 M(+11.9%) |
| Mar 2022 | - | -$67.00 M(-123.8%) | $59.75 M(+10.6%) |
| Dec 2021 | $54.00 M(-143.5%) | $281.02 M(-459.7%) | $54.00 M(-119.4%) |
| Sept 2021 | - | -$78.14 M(+2.6%) | -$278.80 M(+40.0%) |
| June 2021 | - | -$76.14 M(+4.7%) | -$199.11 M(+18.3%) |
| Mar 2021 | - | -$72.75 M(+40.5%) | -$168.35 M(+35.8%) |
| Dec 2020 | -$124.00 M | -$51.78 M(-3436.1%) | -$124.00 M(+38.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $1.55 M(-103.4%) | -$89.75 M(-21.7%) |
| June 2020 | - | -$45.38 M(+59.8%) | -$114.55 M(+16.5%) |
| Mar 2020 | - | -$28.40 M(+62.0%) | -$98.34 M(+10.9%) |
| Dec 2019 | -$88.71 M(+61.7%) | -$17.53 M(-24.6%) | -$88.71 M(+4.8%) |
| Sept 2019 | - | -$23.25 M(-20.3%) | -$84.67 M(+15.1%) |
| June 2019 | - | -$29.16 M(+55.3%) | -$73.56 M(+22.0%) |
| Mar 2019 | - | -$18.77 M(+39.2%) | -$60.30 M(+9.9%) |
| Dec 2018 | -$54.86 M(+2.7%) | -$13.48 M(+11.0%) | -$54.86 M(+0.3%) |
| Sept 2018 | - | -$12.14 M(-23.6%) | -$54.72 M(-16.7%) |
| June 2018 | - | -$15.90 M(+19.3%) | -$65.71 M(+10.5%) |
| Mar 2018 | - | -$13.33 M(-0.1%) | -$59.47 M(+11.3%) |
| Dec 2017 | -$53.44 M(+193.9%) | -$13.34 M(-42.3%) | -$53.44 M(+33.3%) |
| Sept 2017 | - | -$23.13 M(+139.4%) | -$40.10 M(+136.4%) |
| June 2017 | - | -$9.66 M(+32.4%) | -$16.96 M(+132.4%) |
| Mar 2017 | - | -$7.30 M | -$7.30 M |
| Dec 2016 | -$18.18 M | - | - |
FAQ
- What is Arcus Biosciences annual operaing income?
- What is the all time high annual operating profit for Arcus Biosciences?
- What is Arcus Biosciences annual operating profit year-on-year change?
- What is Arcus Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Arcus Biosciences?
- What is Arcus Biosciences quarterly operating profit year-on-year change?
- What is Arcus Biosciences TTM operating income?
- What is the all time high TTM operating profit for Arcus Biosciences?
- What is Arcus Biosciences TTM operating profit year-on-year change?
What is Arcus Biosciences annual operaing income?
The current annual operating profit of RCUS is -$340.00 M
What is the all time high annual operating profit for Arcus Biosciences?
Arcus Biosciences all-time high annual operaing income is $54.00 M
What is Arcus Biosciences annual operating profit year-on-year change?
Over the past year, RCUS annual operaing income has changed by -$60.00 M (-21.43%)
What is Arcus Biosciences quarterly operating income?
The current quarterly operating profit of RCUS is -$105.00 M
What is the all time high quarterly operating profit for Arcus Biosciences?
Arcus Biosciences all-time high quarterly operating income is $281.02 M
What is Arcus Biosciences quarterly operating profit year-on-year change?
Over the past year, RCUS quarterly operating income has changed by -$25.00 M (-31.25%)
What is Arcus Biosciences TTM operating income?
The current TTM operating profit of RCUS is -$298.00 M
What is the all time high TTM operating profit for Arcus Biosciences?
Arcus Biosciences all-time high TTM operating income is $75.02 M
What is Arcus Biosciences TTM operating profit year-on-year change?
Over the past year, RCUS TTM operating income has changed by +$25.00 M (+7.74%)